de Laka-catalogus

nr titelauteurdatum
6.07.4.60/47Nuclear Medicine's Double Hazard. Imperiled Treatment and the Risk of TerrorismC.Hanselljuli 2008
6.07.4.60/46European Research Reactor Position Paper. Scenario for sustainable Molybdenum-99 production in EuropeCEA, NCBJ, NRG, PALLAS, RCR, SCK•CEN, TUMjuni 2018
6.07.4.60/45Emissions from Fission-Based Medical Isotope Production and their Effects on the International Monitoring SystemTh.W.Bowyermei 2015
6.07.4.60/44Maximum reasonable radioxenon releases from medical isotope production facilities and their effect on monitoring nuclear explosionsTh.W.Bowyer, R.kephart, P.W.Eslinger, J.Frieseseptember 2012
6.07.4.60/43Isotopic noble gas signatures released from medical isotope production facilities- Simulations and measurementsP.Saey, Th.W.Bowyer, A.Ringbomapril 2010
6.07.4.60/42Marktontwikkeling en leveringszekerheid voor medische radionucliden, aanvullingRoobol, de Waard, RIVMseptember 2019
6.07.4.60/41Marktontwikkeling en leveringszekerheid voor medische radionucliden Roobol, de Waard, RIVMjuli 2019
6.07.4.60/40Medical isotope production using Lighthouse acceleratorJ.W.Blokkernovember 2017
6.07.4.60/39Production Of 99Tc On A Medical Cyclotron: A Feasibility StudyJ.E.Beaver. H.B.Hupfnovember 1971
6.07.4.60/38Marktontwikkeling en leveringszekerheid voor medische isotopenRoobol, de Waard, RIVMapril 2018
6.07.4.60/37Medical isotopes. Global importance and opportunities for the Netherlands in a European context Nucleair Nederlandnovember 2017
6.07.4.60/362016 Medical Isotope Supply ReviewNEAjuni 2016
6.07.4.60/35Alternatives for the production of medical isotopesGreenpeace Netherlands, Profundo, J.W.van Gelder, A.Herdermaart 2010
6.07.4.60/34Radio-activiteit in dienst van de artsAO-reeks, T.van Leeuwennovember 1976
6.07.4.60/33Medische isotopen. Belang voor de wereld en kansen voor NederlandNucleair Nederlandapril 2017
6.07.4.60/32Feasibility of Producing Molybdenum-99 on a Small Scale Using Fission of Low Enriched Uranium or Neutron Activation of Natural MolybdenumIAEAjanuari 2015
6.07.4.60/31Cyclotron Based Production of Technetium-99mIAEAjuni 2017
6.07.4.60/30Productie en gebruik van medische radio-isotopen in Nederland - Huidige situatie en toekomstverkenningRIVM, Roobol, van der Reijden, de Waard–Schalk, Bijwaardjuli 2017
6.07.4.60/292017 Medical Isotope Supply Review: Mo/Tc Market Demand and Production Capacity Projection 2017-2022OECD, NEAapril 2017
6.07.4.60/28Ruwe schets van de problemen voor de behandeling van Nederlandse patiënten bij een plotselinge productiestop van medische isotopen in NederlandRIVM, Smetsers, Bijwaard, Rooboljuli 2016
6.07.4.60/27Molybdenum-99 for Medical ImagingNational Academies of Sciencesseptember 2016
6.07.4.60/26Co-production of medical radioisotopes in the proposed Accelerator Production of Tritium FacilityLANLdecember 1998
6.07.4.60/25Future Supply of Medical Radioisotopes for the UK Report 2014British Nuclear Medicine Society, Science & Technology Facilities Councilnovember 2014
6.07.4.60/24Nuclear Medicine without Nuclear Reactors or Uranium EnrichmentAAAS, Updegraff, Hoedlmei 2013
6.07.4.60/23The Supply of Medical Radioisotopes. Implementation of the HLG-MR Policy Approach. Results from a Self-assessment by the Global 99Mo/99mTc Supply ChainOECD, NEAmaart 2013
6.07.4.60/22Straling in ziekenhuizenAbvaKabo
6.07.4.60/21Working materials Consultancy on Conversion planning for Mo-99 Production facilities from HEU to LEUIAEAaugustus 2010
6.07.4.60/20Radioisotopes and life processesW.Kosieleski, R.Baserga1967
6.07.4.60/19Radioisotopes in MedicineE.W.Phelan, AEC1966
6.07.4.60/18Report on Molybdenum 99 production for nuclear medicine 2010-2020AIPESnovember 2008